Business context and reporting period
Cognyte Software Ltd. provides investigative analytics software to government and enterprise customers. This is its Form 20-F annual report for the fiscal year ended January 31, 2022, filed April 5, 2022, with comparative figures for fiscal 2021 and 2020. The request metadata says “2020 Q4,” but the filing covers FY2022, not a 2020 quarter. FY2022 was the company’s first full fiscal year as an independent public company after its February 1, 2021 spin-off from Verint. Financial statements are audited and prepared under U.S. GAAP; FY2021 and FY2020 comparatives are carved out from Verint’s records.
Key financial metrics
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $474.0 million | $443.5 million |
| Gross profit / gross margin | $341.6 million / 72.1% | $310.8 million / 70.1% |
| Operating income / margin | $11.0 million / 2.3% | $18.3 million / 4.1% |
| Net income (loss) attributable to Cognyte | $(14.9) million | $14.2 million |
| Operating cash flow | $2.6 million | $71.3 million |
| Capital expenditures | $17.8 million | $19.3 million |
| Cash and cash equivalents | $152.6 million | $78.6 million |
| Short-term investments | $10.4 million | $4.7 million |
| Short-term loan | $100.0 million | None reported |
Cash, cash equivalents, restricted cash and short-term investments totaled $166.6 million at January 31, 2022; some cash was restricted. Total liabilities were $365.5 million and stockholders’ equity was $299.1 million. The $100 million revolving-credit-facility draw was classified as a short-term loan and, according to the filing, was due by the end of FY2023’s first quarter. The company reported compliance with its facility covenants.
Material changes versus the prior comparable period
- Revenue rose 7% year over year. Software revenue increased 12% to $210.0 million, and software-service revenue rose 6% to $201.6 million; professional services and other revenue fell 6% to $62.5 million.
- Gross profit increased $30.9 million, and gross margin improved by about 2 percentage points. Software gross margin rose to 86% from 81%; software-service margin edged up to 77% from 76%. Professional-services and other gross margin declined to 10% from 23%.
- Operating income declined $7.3 million as operating expenses increased $38.2 million, including higher R&D and SG&A costs. SG&A included a $4.4 million increase in provision for a legal claim.
- Cognyte moved from $14.2 million of attributable net income to a $14.9 million attributable net loss. The change reflected lower operating income, a $9.1 million unfavorable swing in other income, and a $14.1 million increase in income-tax provision.
- Operating cash flow fell to $2.6 million, primarily as contract liabilities decreased $51.3 million, alongside higher receivables and contract assets and lower net income.
- Two government customers represented 23.2% of revenue in FY2022, down from 31.0% in FY2021. Government contracts generated approximately 88% of FY2022 revenue; approximately 96% of revenue came from existing customers.
Outlook, management commentary, risks and unusual items
- Management stated that cash, cash equivalents, short-term investments and expected operating cash generation should fund operations, working capital, ordinary capital expenditures, R&D and other commitments for at least 12 months. No specific revenue or earnings guidance is provided in the supplied filing text.
- Management described an improving business environment in 2021, but said COVID-19 continued to delay large contracts, customer deployments and revenue recognition. Supply-chain shortages and higher freight, materials and labor costs were expected to persist into 2022. The filing also discusses the Ukraine conflict reported after the fiscal year-end and possible effects on markets, supply chains and Cognyte’s Eastern European operations.
- Spin-off costs were $11.6 million in FY2022, after $20.3 million in FY2021; management estimated ongoing annual separation-related dis-synergies of approximately $16.5 million.
- The effective income-tax rate was 224.1%, primarily due to a full valuation allowance on deferred tax assets at Cognyte Technologies Israel Ltd. The filing reports $12.7 million of valuation allowance recorded against assets not considered more likely than not to be realized.
- Other income swung to a $2.7 million expense from $6.4 million of income, mainly because of foreign-currency losses and lower investment gains and interest income. Foreign exchange movements reduced FY2022 operating income by an estimated $8.9 million compared with unchanged prior-year exchange rates.
- Cognyte disclosed a December 2021 report by Meta alleging that certain products interfacing with Facebook and Instagram violated platform terms. Cognyte said it modified features affecting how customers could use the solutions.
- A patent, copyright, trade-secret and contract dispute remains in mediation; the company’s accrual for that matter was $6.2 million at January 31, 2022. The filing also describes an older employee stock-option class-action matter and indemnification arrangements with Verint.
- Other key risks include customer and order concentration, government procurement and termination rights, export-license restrictions, privacy and human-rights scrutiny, cybersecurity, intense competition, talent retention, currency exposure and the shift toward subscription offerings. The company does not anticipate cash dividends in the future.
Important facts for investors to verify
- Confirm the $100 million loan’s repayment date, refinancing status and effect on liquidity after January 31, 2022.
- Track operating cash flow, contract liabilities, receivables and collections, given the sharp cash-flow decline.
- Assess whether revenue growth can translate into operating-profit recovery despite standalone costs, foreign-exchange pressure and weaker professional-services margins.
- Monitor the two major government customers, export-license developments, and any effects from the Meta allegations on product demand or customer relationships.
- Review the progress and potential exposure of the $6.2 million patent-related accrual, other litigation, and the $10.5 million of unrecognized tax benefits disclosed at year-end.
- Evaluate the realization of deferred tax assets and the sustainability of management’s 12-month liquidity assessment.